George Jaiben, Sharma Vijay, Farooque Kamran, Mittal Samarth, Trikha Vivek, Malhotra Rajesh
Department of Orthopedic Surgery, AIIMS, New Delhi, India.
Department of Orthopedic Surgery, JPNA Trauma Centre, AIIMS, New Delhi, India.
Arch Bone Jt Surg. 2024;12(5):342-348. doi: 10.22038/ABJS.2024.76024.3512.
Pre-operative assessment is routinely performed for all hip fractures, and include a thorough clinical examination and multiple pre-operative tests. While abnormalities are often detected in many tests, they have varied effect on mortality. The purpose of the study was to assess the prevalence and impact of these abnormal tests and comorbidities.
This was a prospective study of 283 consecutive hip fracture patients aged above 50 years admitted in a major trauma hospital from February 2019 to December 2019. The prevalence of abnormalities in the following tests were assessed: chest x-ray, electrocardiogram, complete blood count, serum electrolytes, renal function test, prothrombin time/international normalized ratio, and serum bilirubin. Also, presence of comorbidities were recorded. Mortality within 90 days of admission was assessed.
91.5% (N= 259/283) of the patients had at least one abnormal investigation. The most common abnormal investigation was anemia (70.3%, N= 199/283), followed by deranged sodium (36.4%, N= 103/283). 17.7% (N= 50/283) of the patients had at least one new comorbidity diagnosed after admission. The most common newly diagnosed comorbidity was hypertension (10.6%, N= 30/283). Anemia (p=0.044), deranged sodium (p=0.002), raised urea (p=0.018), raised creatinine (p=0.002), renal disease (p=0.015), neurological diseases (p=0.024), and charlson comorbidity index (p=0.004) were associated with increased mortality in multivariate analysis.
Pre-operative hemoglobin, sodium, urea, and creatinine were the most important tests influencing mortality, and derangements of these should therefore be carefully evaluated and managed. Hip fracture care pathways should focus on correction of these abnormalities.
对所有髋部骨折患者常规进行术前评估,包括全面的临床检查和多项术前检查。虽然在许多检查中常发现异常,但它们对死亡率的影响各不相同。本研究的目的是评估这些异常检查和合并症的患病率及影响。
这是一项对2019年2月至2019年12月在一家大型创伤医院收治的283例年龄在50岁以上的连续髋部骨折患者进行的前瞻性研究。评估了以下检查中异常的患病率:胸部X线、心电图、全血细胞计数、血清电解质、肾功能检查、凝血酶原时间/国际标准化比值以及血清胆红素。此外,记录合并症的存在情况。评估入院90天内的死亡率。
91.5%(N = 259/283)的患者至少有一项检查异常。最常见的异常检查是贫血(70.3%,N = 199/283),其次是钠紊乱(36.4%,N = 103/283)。17.7%(N = 50/283)的患者在入院后至少被诊断出一种新的合并症。最常见的新诊断合并症是高血压(10.6%,N = 30/283)。多因素分析显示,贫血(p = 0.044)、钠紊乱(p = 0.002)、尿素升高(p = 0.018)、肌酐升高(p = 0.002)、肾脏疾病(p = 0.015)、神经系统疾病(p = 0.024)以及查尔森合并症指数(p = 0.004)与死亡率增加相关。
术前血红蛋白、钠、尿素和肌酐是影响死亡率的最重要检查,因此应对这些指标的紊乱进行仔细评估和处理。髋部骨折护理路径应注重纠正这些异常情况。